DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3z5ng3/conjunctivitis) has announced the addition of the "Conjunctivitis Partnering 2009-2014" report to their offering.
Conjunctivitis Partnering 2009-2014 report provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare companies.
- Trends in conjunctivitis partnering deals
- Top conjunctivitis deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type
Conjunctivitis Partnering 2009-2014 provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of conjunctivitis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors conjunctivitis technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of conjunctivitis technologies and products.
Conjunctivitis Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to conjunctivitis trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
- Trends in conjunctivitis dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- The leading conjunctivitis deals by value since 2009
In Conjunctivitis Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in conjunctivitis partnering
Chapter 3 - Leading conjunctivitis deals
Chapter 4 - Dealmaking directory
Chapter 5 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/3z5ng3/conjunctivitis